All Bell ceremonies

Gong marks partnership Bruna and Woutertje Pieterse Award

CEO of Bruna, Fred Zeegers, sounds the gong to mark the partnership between Bruna and the Woutertje Pieterse Award.  PostNL and ING, listed on the Amsterdam Exchange, are shareholders of Postkantoren BV, of which Bruna is a wholly owned subsidiary.

The new partnership guarantees the continued existence of the prestigious award for children’s literature, and the announcement of the 28th winner will therefore take place on 11 April of this year. In anticipation of the announcement and for the first time in the history of the Woutertje Pieterse Award, nominees have been made public.

For more information: www.woutertjepieterseprijs.nl 

Download photo

Welcome to Focus Home Interactive on Alternext Paris

Jean-Pierre Bourdon, President of the board of Directors, Focus Home Interactive rings the opening bell.

Focus Home Interactive specializes in the publishing and distribution of video games for PCs and consoles.
The company has a catalogue of original titles (Blood Bowl, Sherlock Holmes, TrackMania, Runaway, Cycling Manager, Virtual Skipper, etc.).

Welcome to Focus Home Interactive on Alternext Paris

Jean-Pierre Bourdon, President of the board of Directors, Focus Home Interactive rings the opening bell.

Focus Home Interactive specializes in the publishing and distribution of video games for PCs and consoles.
The company has a catalogue of original titles (Blood Bowl, Sherlock Holmes, TrackMania, Runaway, Cycling Manager, Virtual Skipper, etc.).

Tronics Microsystems celebrates IPO on Alternext Paris

In the context of the initial public offering of Tronics, a designer and manufacturer of innovative nano and microsystems, Mr Pascal Langlois, Chief Executive Officer, Mr Stephane Renard, Founder and Chief Technology Officer and Mrs Laurence Fayand, Chief Financial Officer, open the European trading day in Paris.

Tronics designs, manufactures and sells custom or standard products in the sector of nano & microsystems with high added value.

Founded in 1997, Tronics is a recognized technological leader in the sector of nano & microsystems with high added value.
Positioned at the heart of product innovation, Tronics has technology platforms protected by a portfolio of 25 families of patents, resulting from 15 years of R&D and more than €15 million of cumulative industrial investments.
Addressing high-growth markets relying on increasing miniaturization of electronic devices, Tronics designs, manufactures and sells custom or standard products to the industry, aeronautics & security, medical and consumer markets.
Located in Crolles, near Grenoble (France) and in Dallas, Texas (United States), Tronics posted revenue of €11.6 million in 2014. It now has 88 employees, of whom 55 are engineers and scientists.

Tronics Microsystems celebrates IPO on Alternext Paris

In the context of the initial public offering of Tronics, a designer and manufacturer of innovative nano and microsystems, Mr Pascal Langlois, Chief Executive Officer, Mr Stephane Renard, Founder and Chief Technology Officer and Mrs Laurence Fayand, Chief Financial Officer, open the European trading day in Paris.

Tronics designs, manufactures and sells custom or standard products in the sector of nano & microsystems with high added value.

Founded in 1997, Tronics is a recognized technological leader in the sector of nano & microsystems with high added value.
Positioned at the heart of product innovation, Tronics has technology platforms protected by a portfolio of 25 families of patents, resulting from 15 years of R&D and more than €15 million of cumulative industrial investments.
Addressing high-growth markets relying on increasing miniaturization of electronic devices, Tronics designs, manufactures and sells custom or standard products to the industry, aeronautics & security, medical and consumer markets.
Located in Crolles, near Grenoble (France) and in Dallas, Texas (United States), Tronics posted revenue of €11.6 million in 2014. It now has 88 employees, of whom 55 are engineers and scientists.

Elis celebrates IPO on Euronext Paris

Xavier Martiré, CEO, Elis rings the European trading day in Paris.

Elis is a full-services group leader in Europe and Brazil in the rental and maintenance of professional clothing and linen, offering additional services such as water fountains, rugs and sanitation.
With more than 18,500 employees in 10 European countries and Brazil, ELIS realized in 2013 a turnover of more than 1.225 billion euros. With over a century of expertise in its traditional markets of hotel, catering and health, ELIS now delivers over 240 000 companies of all sizes and in all sectors through its network of more than 256 service centers and production, which guarantees unparalleled customer proximity.

Elis celebrates IPO on Euronext Paris

Xavier Martiré, CEO, Elis rings the European trading day in Paris.

Elis is a full-services group leader in Europe and Brazil in the rental and maintenance of professional clothing and linen, offering additional services such as water fountains, rugs and sanitation.
With more than 18,500 employees in 10 European countries and Brazil, ELIS realized in 2013 a turnover of more than 1.225 billion euros. With over a century of expertise in its traditional markets of hotel, catering and health, ELIS now delivers over 240 000 companies of all sizes and in all sectors through its network of more than 256 service centers and production, which guarantees unparalleled customer proximity.

EnterNext welcomes Safe Orthopaedics on Euronext in Paris

Yves Vignancour, CEO of Safe Orthopaedics, rings the opening bell.

Safe Orthopaedics specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable).

EnterNext welcomes Safe Orthopaedics on Euronext in Paris

Yves Vignancour, CEO of Safe Orthopaedics, rings the opening bell.

Safe Orthopaedics specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable).

Duallisting of Bone Therepeutics in Brussels and Paris

As of 6 February 2015, the Biotech company Bone Therapeutics is listed both on Brussels and Paris. To celebrate this event, CEO Enrico Bastianelli opened the markets with a Bell Ceremony. Wim Goemaere, CFO, had the honor to write the first opening price on the blackboard. Minister Jean-Claude Marcourt, Vice-Minister-President and Minister of Economy of the Walloon Government was our guest of honour.

Bone Therapeutics raised €32.2M in a 2,5 oversubscribed successful IPO on Euronext Brussels and Paris. The reference price was fixed at €16. Market cap amounts to €104.8M on the day of its introduction. With the funds, Bone Therapeutics will accelerate development of their innovative bone cell therapy products for fracture repair and prevention.

Bone Therapeutics  is a biotechnology company and specializes in the development of cell therapy products  for the treatment of osteo-articular diseases and regeneration of bone tissue, based on a technological platform permitting the production of osteoblastic cells from adult stem cells. This therapeutic domain concerns bone reconstruction application and the treatment of diseases such as osteoporosis.

The ticker code is : BOTHE.

If you would like to find out more : www.bonetherapeutics.com/en

EnterNext is the most active European market place in the Life Sciences sector with a market share close to 30% in terms of capital raised at IPO.   The biotech franchise listed on Enternext represents over €6.2bn in market capitalisation for 31 issuers.  At Enternext Brussels,  7 Biotech companies represent €2.2bn in market capitalisation. In the recent years, our Next Biotech Index has outperformed most of the main European indices.

EnterNext welcomes Poxel on Euronext in Paris

Thomas Kuhn, CEO of Poxel, rings the opening bell.

Poxel is a biopharmaceutical company that specializes in the development of medicines for the treatment of metabolic diseases, primarily type II diabetes.

At the end of 2014, the group had 6 products including 1 in phase II of clinical development (Imeglimin), 1 in phase of preclinical development (PXL770) and 4 in research phase.

EnterNext welcomes Poxel on Euronext in Paris

Thomas Kuhn, CEO of Poxel, rings the opening bell.

Poxel is a biopharmaceutical company that specializes in the development of medicines for the treatment of metabolic diseases, primarily type II diabetes.

At the end of 2014, the group had 6 products including 1 in phase II of clinical development (Imeglimin), 1 in phase of preclinical development (PXL770) and 4 in research phase.

Methorios Capital celebrates listing on Alternext

Fabio Palumbo, Chairman of METHORIOS opens the European trading day in Paris to celebrate their listing on Alternext.

Methorios Capital specializes in providing advisory in corporate finance transactions and assistance to small and medium companies in the research of financial solutions and corporate structures. The group's activity is organized into two sectors:
corporate finance advisory: advisory in mergers and acquisitions, in industrial and financial reorganizations, in renegotiations of lines of credit, in debt restructuring, provision of valuations of companies, implementation of strategic analyses, etc.;
investment banking: equity investment and capital markets.

Methorios Capital celebrates listing on Alternext

Fabio Palumbo, Chairman of METHORIOS opens the European trading day in Paris to celebrate their listing on Alternext.

Methorios Capital specializes in providing advisory in corporate finance transactions and assistance to small and medium companies in the research of financial solutions and corporate structures. The group's activity is organized into two sectors:
corporate finance advisory: advisory in mergers and acquisitions, in industrial and financial reorganizations, in renegotiations of lines of credit, in debt restructuring, provision of valuations of companies, implementation of strategic analyses, etc.;
investment banking: equity investment and capital markets.

EnterNext welcomes Oceasoft on Alternext in Paris

Laurent Rousseau, CEO of Oceasoft, rings the opening bell.

Oceasoft specializes in the design, manufacture and marketing of surveillance systems for physical parameters (temperature, humidity, CO2 rate or differential pressure) for the healthcare and agro-food industries. The data captured by these connected sensors ensure real-time control and tracking of products sensitive to environmental parameters, such as vaccines, drugs or foodstuffs, during their manufacture as well as during storage and transport.
55.2% of the company's turnover is made in France.

EnterNext welcomes Oceasoft on Alternext in Paris

Laurent Rousseau, CEO of Oceasoft, rings the opening bell.

Oceasoft specializes in the design, manufacture and marketing of surveillance systems for physical parameters (temperature, humidity, CO2 rate or differential pressure) for the healthcare and agro-food industries. The data captured by these connected sensors ensure real-time control and tracking of products sensitive to environmental parameters, such as vaccines, drugs or foodstuffs, during their manufacture as well as during storage and transport.
55.2% of the company's turnover is made in France.

Danone opens bond market with historical coupon at 1,125%

Pierre André Terisse, CFO of Danone Group, in the presence of the teams participating in the operation, celebrates the  €1,3 billion dual tranche bond issue of the 7th of January 2015.

Danone is a regular issuer on the bond market under EMTN programme since 1996. This year, Danone opened the market with a dual tranche operation, a 5-year floating rate note of  550 millions euros  (coupon of Euribor 3 months +à,33%) and a 10-year fixed rate bond of 750 millions euros  (coupon of 1,125%) and thus, reinforces the financial structure of the group. This operation was widely subscribed and enables to finance the development of the group at very attractive conditions.

Danone opens bond market with historical coupon at 1,125%

Pierre André Terisse, CFO of Danone Group, in the presence of the teams participating in the operation, celebrates the  €1,3 billion dual tranche bond issue of the 7th of January 2015.

Danone is a regular issuer on the bond market under EMTN programme since 1996. This year, Danone opened the market with a dual tranche operation, a 5-year floating rate note of  550 millions euros  (coupon of Euribor 3 months +à,33%) and a 10-year fixed rate bond of 750 millions euros  (coupon of 1,125%) and thus, reinforces the financial structure of the group. This operation was widely subscribed and enables to finance the development of the group at very attractive conditions.